Sex disparity for patients with cutaneous squamous cell carcinoma of the Head and Neck: a systematic review
Simple Summary This is a systematic and meta-analysis of proportions study that
investigated the distribution of head and neck cutaneous squamous cell carcinoma between …
investigated the distribution of head and neck cutaneous squamous cell carcinoma between …
Molecular alterations in cutaneous squamous cell carcinoma in immunocompetent and immunosuppressed hosts—A systematic review
DA Tsang, SYC Tam, CC Oh - Cancers, 2023 - mdpi.com
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is the second most common
form of skin cancer worldwide. Due to its high mutational burden, cSCC remains poorly …
form of skin cancer worldwide. Due to its high mutational burden, cSCC remains poorly …
Sex as a predictor of response to immunotherapy in advanced cutaneous squamous cell carcinoma
Simple Summary Cutaneous squamous cell carcinomas (CSCC) are the second most
common skin cancer amongst Caucasians, accounting for up to 20–25% of skin cancers …
common skin cancer amongst Caucasians, accounting for up to 20–25% of skin cancers …
[HTML][HTML] Comparing genomic landscapes of oral and cutaneous squamous cell carcinoma of the head and neck: quest for novel diagnostic markers
R Gupta, D Strbenac, L Satgunaseelan, VKY Cheung… - Modern Pathology, 2023 - Elsevier
Squamous cell carcinoma is the most common head and neck malignancy arising from the
oral mucosa and the skin. The histologic and immunohistochemical features of oral …
oral mucosa and the skin. The histologic and immunohistochemical features of oral …
[HTML][HTML] P53 and the ultraviolet radiation-induced skin response: Finding the light in the darkness of triggered carcinogenesis
This review delves into the significant cellular and molecular responses triggered by UVR
exposure in human skin, emphasizing the pivotal role of mutant p53 (mutp53) in the …
exposure in human skin, emphasizing the pivotal role of mutant p53 (mutp53) in the …
[HTML][HTML] Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions
J Conley, B Genenger, B Ashford… - International Journal of …, 2024 - mdpi.com
The keratinocyte carcinomas, basal cell carcinoma (BCC), and cutaneous squamous cell
carcinoma (cSCC), are the most common cancers in humans. Recently, an increasing body …
carcinoma (cSCC), are the most common cancers in humans. Recently, an increasing body …
PIK your poison: the effects of combining PI3K and CDK inhibitors against metastatic cutaneous squamous cell carcinoma in vitro
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is a very common skin
cancer with poor prognosis for patients with advanced disease. PI3K/AKT/mTOR and cell …
cancer with poor prognosis for patients with advanced disease. PI3K/AKT/mTOR and cell …
Evolution of head and neck cutaneous squamous cell carcinoma nodal staging—an Australian perspective
Simple Summary Australia has the highest incidence of cutaneous squamous cell
carcinoma of the head and neck (HNcSCC) in the world. Although the majority of HNcSCCs …
carcinoma of the head and neck (HNcSCC) in the world. Although the majority of HNcSCCs …
[HTML][HTML] Dysregulation of mRNA expression by hsa-miR-186 overexpression in arsenic-induced skin carcinogenesis
M Banerjee, A Lykoudi, JY Hwang, J Pan… - Toxicology and Applied …, 2025 - Elsevier
Dysregulated miRNA expression contributes to development of arsenic-induced cutaneous
squamous cell carcinoma (cSCC). hsa-miR-186 (miR-186) is overexpressed in arsenical …
squamous cell carcinoma (cSCC). hsa-miR-186 (miR-186) is overexpressed in arsenical …
Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation
J Conley, JR Perry, B Ashford… - Experimental …, 2024 - Wiley Online Library
Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy
worldwide, with most deaths caused by locally advanced and metastatic disease. Treatment …
worldwide, with most deaths caused by locally advanced and metastatic disease. Treatment …